76 related articles for article (PubMed ID: 17466515)
41. Can environmental estrogens cause breast cancer?
Davis DL; Bradlow HL
Sci Am; 1995 Oct; 273(4):167-72. PubMed ID: 7481720
[No Abstract] [Full Text] [Related]
42. Oestrogens, adipose tissues and environmental exposures influence obesity and diabetes across the lifecycle.
Bardhi O; Dubey P; Palmer BF; Clegg DJ
Proc Nutr Soc; 2024 Feb; ():1-8. PubMed ID: 38305136
[TBL] [Abstract][Full Text] [Related]
43. Oestrogenic substances contained in the fatty tissue of a mammary gland affected by carcinoma, compared with the morphological changes in its parenchyma.
RAICHEV R; ALEXANDROV K
Neoplasma; 1961; 8():247-52. PubMed ID: 13739160
[No Abstract] [Full Text] [Related]
44. New window into breast cancer risk.
Mead MN
Environ Health Perspect; 2008 Jul; 116(7):A307. PubMed ID: 18629343
[No Abstract] [Full Text] [Related]
45. Anti-oestrogenic effect of cigarette smoking.
Lancet; 1986 Dec 20-27; 2(8521-22):1433. PubMed ID: 2878283
[No Abstract] [Full Text] [Related]
46. Total Effective Xenoestrogen Burden in Serum Samples and Risk of Endometrial Cancer in the Spanish Screenwide Case-Control Study.
Costas L; Frias-Gomez J; Peinado FM; Molina-Molina JM; Peremiquel-Trillas P; Paytubi S; Crous-Bou M; de Francisco J; Caño V; Benavente Y; Pelegrina B; Martínez JM; Pineda M; Brunet J; Matias-Guiu X; de Sanjosé S; Ponce J; Olea N; Alemany L; Fernández MF
Environ Health Perspect; 2024 Feb; 132(2):27012. PubMed ID: 38415615
[TBL] [Abstract][Full Text] [Related]
47. Endocrine-Mediated Mechanisms of Metabolic Disruption and New Approaches to Examine the Public Health Threat.
Kassotis CD; Stapleton HM
Front Endocrinol (Lausanne); 2019; 10():39. PubMed ID: 30792693
[TBL] [Abstract][Full Text] [Related]
48. Associations of Fetal Growth Outcomes with Measures of the Combined Xenoestrogenic Activity of Maternal Serum Perfluorinated Alkyl Acids in Danish Pregnant Women.
Bjerregaard-Olesen C; Bach CC; Long M; Wielsøe M; Bech BH; Henriksen TB; Olsen J; Bonefeld-Jørgensen EC
Environ Health Perspect; 2019 Jan; 127(1):17006. PubMed ID: 30676078
[TBL] [Abstract][Full Text] [Related]
49. Total Effective Xenoestrogen Burden in Serum Samples and Risk for Breast Cancer in a Population-Based Multicase-Control Study in Spain.
Pastor-Barriuso R; Fernández MF; Castaño-Vinyals G; Whelan D; Pérez-Gómez B; Llorca J; Villanueva CM; Guevara M; Molina-Molina JM; Artacho-Cordón F; Barriuso-Lapresa L; Tusquets I; Dierssen-Sotos T; Aragonés N; Olea N; Kogevinas M; Pollán M
Environ Health Perspect; 2016 Oct; 124(10):1575-1582. PubMed ID: 27203080
[TBL] [Abstract][Full Text] [Related]
50. Gestational bisphenol A exposure and testis development.
Williams C; Bondesson M; Krementsov DN; Teuscher C
Endocr Disruptors (Austin); 2014; 2(1):. PubMed ID: 26167515
[TBL] [Abstract][Full Text] [Related]
51. New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidence.
Rudel RA; Ackerman JM; Attfield KR; Brody JG
Environ Health Perspect; 2014 Sep; 122(9):881-95. PubMed ID: 24818537
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of histone proteins during estrogen-mediated cell proliferation.
Zhu Z; Edwards RJ; Boobis AR
Environ Health Perspect; 2009 Jun; 117(6):928-34. PubMed ID: 19590685
[TBL] [Abstract][Full Text] [Related]
53. The total effective xenoestrogen burden, a biomarker of exposure to xenoestrogen mixtures, is predicted by the (anti)estrogenicity of its components.
Fernandez MF; Aguilar-Garduño C; Molina-Molina JM; Arrebola JP; Olea N
Reprod Toxicol; 2008 Sep; 26(1):8-12. PubMed ID: 18586082
[TBL] [Abstract][Full Text] [Related]
54. Changes in the total effective xenoestrogen burden (TEXB) of breast cancer patients during an 18-month post-surgical follow-up.
Fernandez MF; Pumarega J; Porta M; Molina-Molina JM; Arrebola JP; Olea N
Reprod Toxicol; 2017 Apr; 69():212-220. PubMed ID: 28288811
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective.
Kortenkamp A
Int J Androl; 2006 Feb; 29(1):193-8. PubMed ID: 16466540
[TBL] [Abstract][Full Text] [Related]
56. The lipidome as a composite biomarker of the modifiable part of the risk of breast cancer.
Bougnoux P; Hajjaji N; Couet C
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):93-6. PubMed ID: 18930643
[TBL] [Abstract][Full Text] [Related]
57. Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer.
Fernandez MF; Santa-Marina L; Ibarluzea JM; Exposito J; Aurrekoetxea JJ; Torne P; Laguna J; Rueda AI; Pedraza V; Olea N
Eur J Cancer; 2007 May; 43(8):1290-9. PubMed ID: 17466515
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer risk and the combined effect of environmental estrogens.
Ibarluzea Jm Jm; Fernández MF; Santa-Marina L; Olea-Serrano MF; Rivas AM; Aurrekoetxea JJ; Expósito J; Lorenzo M; Torné P; Villalobos M; Pedraza V; Sasco AJ; Olea N
Cancer Causes Control; 2004 Aug; 15(6):591-600. PubMed ID: 15280638
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
